|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1,665.20 - 1,741.00|
|52 Week Range||1,643.00 - 2,835.00|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||138.74|
|Earnings Date||Aug 19, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2,768.86|
Subscribe to Yahoo Finance Plus to view Fair Value for ADYEN.ASLearn more
For instance, here's one thing you can bet on: Investing in companies at the forefront of growing industries that possess a competitive edge will pay rich dividends down the road. Let's look at two companies that fit this description down to a T: Abbott Laboratories (NYSE: ABT) and Adyen N.V. (OTC: ADYE.Y). Abbott Laboratories is best known as a medical devices specialist -- and it is one of the most established leaders in this field.
Adyen, the global payments platform of choice for many of the world's leading companies, today announced the launch of mobile Android point of sale (POS) terminals in the EU, UK, and the United States. The devices represent a fundamental change in the role of the payment terminal, functioning as an all-in-one solution, eliminating the need for separate cash registers, barcode scanners, and customer facing displays. Additionally, the terminals come with an app management system, allowing merchant
Adyen (AMS:ADYEN), the global payments platform of choice for many of the world's leading companies, has been selected by Henry's Enterprises Inc., Canada's leading specialty digital imaging retailer, to process payments across in-store and online commerce channels.